Hospitals

While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles

Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity

Enhanced digital experience designed to improve visibility, simplify workflows and support faster decision-makingBURLINGTON, N.C., Aug. 31, 2026 /PRNewswire/ -- Labcorp (NYSE:...

error: Content is protected !!